ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	13/79	191/7206	1.20753864186e-07
ko04660	T cell receptor signaling pathway	10/79	124/7206	8.35748231551e-07
ko04380	Osteoclast differentiation	10/79	134/7206	1.71019135874e-06
ko05323	Rheumatoid arthritis	8/79	89/7206	5.0253184973e-06
ko04668	TNF signaling pathway	9/79	120/7206	5.63598639422e-06
ko05140	Leishmaniasis	7/79	75/7206	1.58633307926e-05
ko05131	Shigellosis	7/79	82/7206	2.8574950913e-05
ko05152	Tuberculosis	10/79	187/7206	3.31608201724e-05
ko04670	Leukocyte transendothelial migration	9/79	151/7206	3.61658013327e-05
ko04145	Phagosome	9/79	162/7206	6.28463442187e-05
ko04650	Natural killer cell mediated cytotoxicity	7/79	97/7206	8.46549889214e-05
ko04664	Fc epsilon RI signaling pathway	6/79	77/7206	0.000183022055238
ko04666	Fc gamma R-mediated phagocytosis	7/79	122/7206	0.000354587883454
ko04672	Intestinal immune network for IgA production	4/79	37/7206	0.00067146105983
ko04142	Lysosome	7/79	151/7206	0.00126676977469
ko05144	Malaria	4/79	45/7206	0.00141759439034
ko04062	Chemokine signaling pathway	8/79	201/7206	0.00152311516076
ko04621	NOD-like receptor signaling pathway	7/79	157/7206	0.00158766955786
ko05330	Allograft rejection	3/79	24/7206	0.00217457482728
ko05164	Influenza A	7/79	167/7206	0.00226005775169
ko04657	IL-17 signaling pathway	5/79	87/7206	0.00255466509376
ko05133	Pertussis	5/79	87/7206	0.00255466509376
ko04662	B cell receptor signaling pathway	5/79	88/7206	0.00268565374344
ko05321	Inflammatory bowel disease (IBD)	4/79	56/7206	0.00319073770193
ko04217	Necroptosis	7/79	178/7206	0.00323453008577
ko04210	Apoptosis	7/79	180/7206	0.00344179371952
ko04064	NF-kappa B signaling pathway	5/79	96/7206	0.00391526119935
ko05340	Primary immunodeficiency	3/79	30/7206	0.00416102001689
ko05132	Salmonella infection	5/79	98/7206	0.00427684512976
ko05100	Bacterial invasion of epithelial cells	5/79	99/7206	0.00446631934173
ko04620	Toll-like receptor signaling pathway	5/79	100/7206	0.0046617154909
ko05150	Staphylococcus aureus infection	3/79	36/7206	0.00698133316865
ko05134	Legionellosis	4/79	74/7206	0.00861884282342
ko05418	Fluid shear stress and atherosclerosis	6/79	173/7206	0.0114907921006
ko05161	Hepatitis B	6/79	173/7206	0.0114907921006
ko05142	Chagas disease (American trypanosomiasis)	5/79	130/7206	0.0137556353589
ko05310	Asthma	2/79	17/7206	0.0145080360651
ko04630	Jak-STAT signaling pathway	5/79	132/7206	0.0146162830718
ko05332	Graft-versus-host disease	2/79	18/7206	0.0162066433233
ko00660	C5-Branched dibasic acid metabolism	1/79	2/7206	0.0218074882853
ko05146	Amoebiasis	4/79	99/7206	0.0229820584453
ko05205	Proteoglycans in cancer	7/79	271/7206	0.0284884128159
ko04640	Hematopoietic cell lineage	3/79	64/7206	0.032765586841
ko04611	Platelet activation	5/79	163/7206	0.0328342138425
ko05320	Autoimmune thyroid disease	2/79	29/7206	0.0398059843105
ko05166	HTLV-I infection	7/79	292/7206	0.0402952665887
ko05162	Measles	4/79	120/7206	0.0422891177823
ko05014	Amyotrophic lateral sclerosis (ALS)	3/79	74/7206	0.0471991278524
ko04940	Type I diabetes mellitus	2/79	32/7206	0.0476212168234
ko05143	African trypanosomiasis	2/79	32/7206	0.0476212168234
ko05168	Herpes simplex infection	5/79	182/7206	0.0489486816494
ko04932	Non-alcoholic fatty liver disease (NAFLD)	5/79	182/7206	0.0489486816494
ko05145	Toxoplasmosis	4/79	126/7206	0.0490885416296